-
SNAP benefits can help you improve your memory
Time of Update: 2023-01-06
Senior author Dr. Adina Zeki Al Hazzouri, assistant professor of epidemiology at Columbia University's Melman School of Public Health, said: "Less than half of older adults who are eligible for the SNAP program actually participated in this study, but our findings suggest that over a 10-year period, people who used the SNAP program experienced two years less cognitive aging than those who did not.
-
U.S. park rangers warn: Please don't lick psychedelic toads
Time of Update: 2023-01-06
?2022 AFP The Sonoran desert toad, also known as the Colorado River toad, lives in the southwestern United States and northwestern Mexico.
?2022 AFP The Sonoran desert toad, also known as the Colorado River toad, lives in the southwestern United States and northwestern Mexico.
-
Cell A nutrient commonly found in the human diet contributes to the survival of a cancer-causing bacterium
Time of Update: 2023-01-06
A microbial transporter of the dietary antioxidant ergothioneine A new study from Yale University has found that a nutrient commonly found in the human diet contributes to the survival of a cancer-causing bacterium.
-
Nature: Mitochondria have a waste disposal mechanism that gets rid of mutated mtDNA
Time of Update: 2023-01-06
"essayMitochondrial membrane proteins and VPS35 orchestrate selective removal of mtDNA Scientists at the University of Cologne have discovered how cells eliminate mutated mitochondrial DNA (mtDNA).
"essayMitochondrial membrane proteins and VPS35 orchestrate selective removal of mtDNA Scientists at the University of Cologne have discovered how cells eliminate mutated mitochondrial DNA (mtDNA).
-
Back from the dead: As many as 32 species of frogs thought to be extinct may not be extinct
Time of Update: 2023-01-06
Photo credit: Alex Achig-VegaThrough a literature review and field investigations, researchers at Michigan State University and collaborators in Ecuador have shown that as many as 32 species of harlequin frogs once thought to be potentially extinct are still alive in the wild.
-
NEJM: Rare fatal genetic disease successfully treated in utero for the first time
Time of Update: 2023-01-06
"From our long work treating patients with Pompe disease at Duke, we know firsthand the critical importance of starting treatment early," said Jennifer Cohen, MD, co-first author of the study and assistant professor in the Department of Pediatric Medical Genetics at Duke University School of Medicine.
-
NEJM: Rare fatal genetic disease successfully treated in utero for the first time
Time of Update: 2023-01-06
"From our long work treating patients with Pompe disease at Duke, we know firsthand the critical importance of starting treatment early," said Jennifer Cohen, MD, co-first author of the study and assistant professor in the Department of Pediatric Medical Genetics at Duke University School of Medicine.
-
Hippo signaling does not direct normal organ growth
Time of Update: 2023-01-06
According to a new study, the Hippo signaling pathway — a genetic program thought to play a central role in organ development — does not direct normal organ growth in fruit flies and mice.
-
Nature: Rejuvenated immune cells do a better job of removing toxic waste from the brain
Time of Update: 2023-01-06
In this study, we treated aged mice with a molecule that activates aged immune cells, which plays a role in improving fluid flow and waste removal in the brain.
-
Luo Huan and Zhang Hang's research group published a paper in Progress in Neurobiology to reveal the dynamic emergence of relationship network structure in the human brain, as well as its neural mechanism and computer theory
Time of Update: 2023-01-06
In summary, Luo Huan and Zhang Hang's research group combined behavioral, neural and computational models to reveal the neural mechanism and computer theory behind the human brain's extraction and learning from continuous picture streams, and then establishing the neural mechanism and computer theory of high-order statistical structure (intracluster compression and intercluster distance) from this low-order transfer probability.
-
There is evidence that SARS-CoV-2 alters the RNA of infected cells
Time of Update: 2023-01-06
Scientists at the Federal University of São Paulo (UNIFESP) in Brazil have demonstrated for the first time that infection with the SARS-CoV-2 virus that causes COVID-19 alters the function of host cell RNA.
-
Minqi Wang's lab published papers at NUTRIENTS
Time of Update: 2023-01-06
3390/nu14193991Published: OCT 2022Document type: ArticleAttachment: Full text link ：Butyrate Glycerides Protect against Intestinal Inflammation and Barrier Dysfunction in Mice（IF=7.
3390/nu14193991Published: OCT 2022Document type: ArticleAttachment: Full text link ：Butyrate Glycerides Protect against Intestinal Inflammation and Barrier Dysfunction in Mice（IF=7.
-
How do you control the number of cells in an organism?
Time of Update: 2023-01-06
"An evolutionarily conserved coronin-dependent pathway defines cell population size If the density of T cells reaches the upper limit, cell death begins.
"An evolutionarily conserved coronin-dependent pathway defines cell population size If the density of T cells reaches the upper limit, cell death begins.
-
Nature sub-journal: Bispecific tumors transform nanoparticles, making the treatment of solid tumors no longer difficult
Time of Update: 2023-01-06
The research developed a nanotechnology platform, bispecific tumor-transforming nanoparticles (BiTNs), that could change the way the immune system responds to solid tumor cells, making solid tumors more sensitive to immunotherapy.
-
Nature Cancer has unveiled a new CRISPR-based technology that can cut the cancer genome and study changes in copy number
Time of Update: 2023-01-06
3 deletions as mediators of immune evasion and metastasis Research focusMACHETE is a new CRISPR-based technique that can efficiently study large-scale gene deletions in laboratory models.
3 deletions as mediators of immune evasion and metastasis Research focusMACHETE is a new CRISPR-based technique that can efficiently study large-scale gene deletions in laboratory models.
-
Severe stressful events can exacerbate symptoms of prolonged COVID (COVID sequelae)
Time of Update: 2023-01-06
The study, led by researchers at New York University's Grossman School of Medicine, found that adult patients with this "primary life stressor" — which was present in more than 50 percent of follow-up patients — were at least twice as likely as other patients to struggle with depression, brain fog, fatigue, sleep problems and other long-term COVID-19 symptoms, the authors said.
-
A low-protein diet can starve cancer cells and overcome resistance to treatment
Time of Update: 2023-01-06
Researchers found in cells and mice that low-protein diets blocked nutrient signaling pathways that activate major regulators of cancer growth.
Researchers found in cells and mice that low-protein diets blocked nutrient signaling pathways that activate major regulators of cancer growth.
-
Cell publishes the functional pattern of basic genes! The function of more than 5,000 genes needed for human cells to survive
Time of Update: 2023-01-06
Using a novel, ensemble, image-based screening method, a team of scientists at the Whitehead Institute, the Massachusetts Institute of Technology and Harvard University's Broad Institute systematically assessed the function of more than 5,000 basic human genes.
-
One injection is effective for a long time, and the clinical data of the Nobel Prize team's second in vivo CRISPR therapy was released
Time of Update: 2023-01-06
On June 24, 2022, Intellia announced interim data from the latest Phase 1 clinical trial of NTLA-2001 therapy, which was positive, and the decline in TTR protein levels in the serum after a single dose was stable and sustained for up to 12 months 。 The main results were as follows: 1.
-
One injection is effective for a long time, and the clinical data of the Nobel Prize team's second in vivo CRISPR therapy was released
Time of Update: 2023-01-06
On June 24, 2022, Intellia announced interim data from the latest Phase 1 clinical trial of NTLA-2001 therapy, which was positive, and the decline in TTR protein levels in the serum after a single dose was stable and sustained for up to 12 months 。 The main results were as follows: 1.
